ProShare Advisors’s Biohaven Pharmaceutical Holding Company Ltd. BHVN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-7,975
| Closed | -$1.21M | – | 1921 |
|
|
2022
Q3 | $1.21M | Sell |
7,975
-58
| -0.7% | -$8.77K | ﹤0.01% | 704 |
|
|
2022
Q2 | $1.17M | Sell |
8,033
-3,816
| -32% | -$556K | ﹤0.01% | 731 |
|
|
2022
Q1 | $1.41M | Sell |
11,849
-1,764
| -13% | -$209K | ﹤0.01% | 804 |
|
|
2021
Q4 | $1.88M | Buy |
13,613
+5,105
| +60% | +$704K | ﹤0.01% | 781 |
|
|
2021
Q3 | $1.18M | Sell |
8,508
-5,509
| -39% | -$765K | ﹤0.01% | 846 |
|
|
2021
Q2 | $1.36M | Buy |
14,017
+1,159
| +9% | +$113K | ﹤0.01% | 865 |
|
|
2021
Q1 | $879K | Buy |
12,858
+2,198
| +21% | +$150K | ﹤0.01% | 1069 |
|
|
2020
Q4 | $914K | Buy |
10,660
+4,763
| +81% | +$408K | ﹤0.01% | 925 |
|
|
2020
Q3 | $383K | Sell |
5,897
-516
| -8% | -$33.5K | ﹤0.01% | 1048 |
|
|
2020
Q2 | $469K | Buy |
+6,413
| New | +$469K | ﹤0.01% | 979 |
|
|
2020
Q1 | – | Sell |
-5,302
| Closed | -$289K | – | 1790 |
|
|
2019
Q4 | $289K | Buy |
+5,302
| New | +$289K | ﹤0.01% | 1356 |
|